drugset / Trial / NCT00974441
Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
This study will compare the relative bioavailability (rate and extent of absorption) of 500 mg Divalproex Sodium (equivalent to 500 mg Valproic Acid) Extended Release Tablets with that of Depakote® ER Tablets following a single oral dose (1 x 500 mg tablet) in healthy adult subjects administered under fasting conditions.
Timeline
- Start
- 2006-08
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Divalproex Sodium | Small molecule | 500 mg | Oral |
Indications
No indication recorded.